These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 18275928)

  • 41. [Genetic and environmental factors in multiple sclerosis].
    Fernández O
    Rev Neurol; 2000 May 16-31; 30(10):964-7. PubMed ID: 10919196
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors.
    Ascherio A; Munger KL
    Ann Neurol; 2007 Jun; 61(6):504-13. PubMed ID: 17492755
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis?
    Pierrot-Deseilligny C; Souberbielle JC
    Brain; 2010 Jul; 133(Pt 7):1869-88. PubMed ID: 20584945
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multiple sclerosis: risk factors, prodromes, and potential causal pathways.
    Ramagopalan SV; Dobson R; Meier UC; Giovannoni G
    Lancet Neurol; 2010 Jul; 9(7):727-39. PubMed ID: 20610348
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Demographic, genetic, and environmental factors that modify disease course.
    Marrie RA
    Neurol Clin; 2011 May; 29(2):323-41. PubMed ID: 21439444
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Epidemiology of multiple sclerosis].
    Delasnerie-Lauprêtre N; Alpérovitch A
    Rev Prat; 1991 Sep; 41(20):1884-7. PubMed ID: 1925370
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Socio-economic factors and immigrant population studies of multiple sclerosis.
    Berg-Hansen P; Celius EG
    Acta Neurol Scand; 2015; 132(199):37-41. PubMed ID: 26046557
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Genetic epidemiology of multiple sclerosis].
    Uría DF
    Rev Neurol; 2002 Nov 16-30; 35(10):979-84. PubMed ID: 12436403
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The geographic distribution of multiple sclerosis: a review.
    Ebers GC; Sadovnick AD
    Neuroepidemiology; 1993; 12(1):1-5. PubMed ID: 8327018
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The multiple sclerosis trait and the development of multiple sclerosis: genetic vulnerability and environmental effect.
    Poser CM
    Clin Neurol Neurosurg; 2006 Mar; 108(3):227-33. PubMed ID: 16406307
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Review of the novelties presented at the 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I)].
    Fernández-Fernández O; Alvarez-Cermeño JC; Arbizu-Urdiain T; Arroyo-González R; Arnal-García C; Casanova-Estruch B; Calles-Hernández MC; Coret-Ferrer F; Comabella M; García-Merino JA; de Las Heras V; Izquierdo G; Meca-Lallana JE; Muñoz-García D; Olascoaga J; Oreja-Guevara C; Prieto JM; Rodríguez-Antigüedad A; Tintoré M; Montalban X;
    Rev Neurol; 2011 Feb; 52(4):227-38. PubMed ID: 21312169
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genes and Environment in Multiple Sclerosis project: A platform to investigate multiple sclerosis risk.
    Xia Z; White CC; Owen EK; Von Korff A; Clarkson SR; McCabe CA; Cimpean M; Winn PA; Hoesing A; Steele SU; Cortese IC; Chitnis T; Weiner HL; Reich DS; Chibnik LB; De Jager PL
    Ann Neurol; 2016 Feb; 79(2):178-89. PubMed ID: 26583565
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multiple sclerosis: does epidemiology contribute to providing etiological clues?
    Granieri E; Casetta I; Tola MR; Govoni V; Paolino E; Malagù S; Monetti VC; Carreras M
    J Neurol Sci; 1993 Apr; 115 Suppl():S16-23. PubMed ID: 8340788
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multiple sclerosis in Australia and New Zealand: are the determinants genetic or environmental?
    Miller DH; Hammond SR; McLeod JG; Purdie G; Skegg DC
    J Neurol Neurosurg Psychiatry; 1990 Oct; 53(10):903-5. PubMed ID: 2266373
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Environmental factors in the development of multiple sclerosis.
    Michel L
    Rev Neurol (Paris); 2018 Jun; 174(6):372-377. PubMed ID: 29735167
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetics of multiple sclerosis in British Columbia and throughout Canada.
    Sadovnick AD
    Ann Neurol; 1994; 36 Suppl():S18-21. PubMed ID: 8017882
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Do male patients with multiple sclerosis have an excess of female offspring?
    Verdier-Taillefer MH; Alpérovitch A
    Neuroepidemiology; 1991; 10(1):18-23. PubMed ID: 2062412
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Timing of birth and risk of multiple sclerosis: population based study.
    Willer CJ; Dyment DA; Sadovnick AD; Rothwell PM; Murray TJ; Ebers GC;
    BMJ; 2005 Jan; 330(7483):120. PubMed ID: 15585537
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multiple sclerosis in stepsiblings: recurrence risk and ascertainment.
    Dyment DA; Yee IM; Ebers GC; Sadovnick AD;
    J Neurol Neurosurg Psychiatry; 2006 Feb; 77(2):258-9. PubMed ID: 16421134
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic epidemiology: the use of old and new tools for multiple sclerosis.
    Ramagopalan SV; Dyment DA; Ebers GC
    Trends Neurosci; 2008 Dec; 31(12):645-52. PubMed ID: 18952304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.